Cited by 122Drug Transport and Resistance MechanismsCholesterol and Lipid MetabolismReceptor Mechanisms and Signaling

TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders

Tiwari, Atul, Maiti, Pranab·2009·Drug Discovery Today

Abstract

Over the past decade, new roles for bile acids in paracrine and endocrine regulation of cholesterol homeostasis, lipid and carbohydrate metabolism and immunomodulatory functions have been discovered. Most of the early discoveries focused on the genomic actions of bile acids through the activation of families of nuclear receptors, such as the farnesoid X receptor and vitamin D receptors, until a new chapter in the bile acid receptor discovery unfolded in the form of TGR5; a novel G-protein-coupled receptor mediating several non-genomic functional responses induced by binding of bile acids. The key involvement of TGR5 in mediating energy homeostasis and glucose homeostasis made it an attractive target for the potential treatment of metabolic disorders.

Integrity signals

Registry

Crossref · 10.1016/j.drudis.2009.02.005

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • One TGR5 agonist, INT-777, has shown efficacy in vivo, increasing energy expenditure and reducing adiposity in mice with diet-induced obesity.

    “One promising TGR5 agonist, INT-777, has already shown efficacy in vivo, increasing energy expenditure and reducing adiposity in mice with diet-induced obesity 148,149.”

    From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [149]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tiwari, A., & Maiti, P.
Corresponding author
Tiwari, Atul
Venue
Drug Discovery Today
Publisher
Elsevier BV
Published
2009-05
Volume
14
Issue
9-10
Pages
523-530
ISSN
1359-6446 (ISSN-L)
OpenAlex
W2065880381
Cited by
122
References
54
Citations by year
2026: 3 · 2025: 3 · 2024: 7 · 2023: 10 · 2022: 3 · 2021: 5 · 2020: 7 · 2019: 5 · 2018: 6 · 2017: 7 · 2016: 11 · 2015: 10 · 2014: 8 · 2013: 11 · 2012: 7
FWCI
0.82
Type
journal article
Language
en
Open access
closed
Locations
  • Drug Discovery Today (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
TGR5, G protein-coupled receptors, bile acids, metabolic disorders, glucose homeostasis, energy homeostasis, cholesterol homeostasis, lipid metabolism, carbohydrate metabolism, immunomodulation, therapeutic target
MeSH terms
Animals, Bile Acids and Salts, Energy Metabolism, Glucose, Homeostasis, Humans, Metabolic Diseases, Models, Biological, Drug Delivery Systems, Receptors, G-Protein-Coupled

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review